DUBLIN, Ireland--(BUSINESS WIRE)-- Covidien (NYSE: COV) today announced CE Mark approval for its Nellcor™ Bedside SpO 2 Patient Monitoring System, PM100N. The system currently is available in the ...

Covidien has announced it has received FDA clearance to market the Covidien Nellcor Bedside SpO2 Patient Monitoring System, according to a news release. The Nellcor Bedside SpO2 system includes the ...

<0> CovidienRhonda Luniak, 303-305-2263Vice PresidentR&MS CommunicationsorBruce Farmer, 508-452-4372Vice PresidentPublic RelationsorColeman Lannum, CFA, 508-452-4343Vice PresidentInvestor ...

Medtronic plc MDT recently announced favourable outcome of an independent prospective observational study, which was published online in the Journal of Perinatology. This study compared the efficacy ...

Leading health care products company, Covidien plc. (COV) recently won the U.S. Food and Drug Administration (:FDA) 510(k) approval as well as the European Economic Area (EEA) CE Mark clearance for ...

The U.S. Food and Drug Administration has granted Covidien 510(k) clearance to market the company’s Nellcor Bedside SpO2 Patient Monitoring System. The Nellcor Bedside SpO2 system with OxiMax ...

International healthcare products major, Covidien plc ( COV) has started labeling its Nellcor pulse oximeters to promote the usefulness of the product line for Critical Congenitial Heart Disease (CCHD ...

Nellcor pulse oximeters only FDA 510(k)-cleared oximeters compliant with ISO 80601-2-61 BOULDER, Colo.--(BUSINESS WIRE)-- Covidien, a leading global provider of healthcare products and recognized ...

Covidien (NYSE: COV) today announced CE Mark approval for its Nellcor™ Bedside SpO 2 Patient Monitoring System, PM100N. The system currently is available in the European Economic Area (EEA), Australia ...

Covidien Receives FDA 510(k) Clearance for Nellcor™ Pulse Oximetry Motion Claims Nellcor pulse oximeters only FDA 510(k)-cleared oximeters compliant with ISO 80601-2-61 BOULDER, Colo.--(BUSINESS WIRE) ...